PLx Pharma Inc.
PLXPNASDAQHealthcare
$0.09
+$0.00(+0.00%)
Market Cap$2534980
P/E Ratio—
52W High$3.41
52W Low$0.009
PLx Pharma Inc. (PLXP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PLXP · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $8.21M | $0.03M | $0.57M | $0.75M | $0.78M |
| Cost of Revenue | $4.80M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $3.40M | $0.03M | $0.57M | $0.75M | $0.78M |
| Gross Margin %(computed) | 41.46% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $4.18M | $4.34M | $4.74M | $3.92M | $4.16M |
| G&A Expenses | $0.00M | $9.15M | $10.03M | $7.79M | $10.17M |
| Total Operating Expenses | $44.19M | $13.49M | $14.77M | $11.71M | $14.33M |
| Operating Income | ($40.79M) | ($13.46M) | ($14.20M) | ($10.96M) | ($15.85M) |
| Operating Margin %(computed) | -496.95% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.41M | $0.30M | $0.11M |
| Interest Expense | $0.00M | $0.31M | $0.99M | $1.15M | $1.16M |
| Income Before Tax | ($46.13M) | ($15.21M) | ($20.50M) | $0.90M | ($16.27M) |
| Income Tax Expense | $5.33M | ($0.11M) | $0.84M | $0.00M | ($0.92M) |
| Net Income | ($51.46M) | ($15.10M) | ($21.34M) | $0.90M | ($15.35M) |
| Net Margin %(computed) | -626.95% | — | — | 119.04% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.18 | $-1.55 | $-2.39 | $0.10 | $-2.19 |
| Wtd Avg Shares | 23.65M | 9.71M | 8.92M | 8.73M | 7.02M |
| EBITDA | ($35.24M) | ($14.49M) | ($13.80M) | $2.24M | ($15.10M) |
| EBITDA Margin %(computed) | -429.35% | — | — | 297.86% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more PLx Pharma Inc. data
About PLx Pharma Inc. (PLXP) Income Statement
PLx Pharma Inc. (PLXP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, PLXP reported revenue of $0.01B, gross profit of $0.00B (gross margin 41.46%), and net income of ($0.05B) — a net profit margin of -626.95%.
Frequently asked questions
PLXP · 4 questionsPLx Pharma Inc. (PLXP) reported revenue of $0.01B for 2021, up 26873.4% year-over-year.
PLXP revenuePLXP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09